Search research articles
Contact Us
Filters
Showing results (91-100 of 358) with videos related to
Page
of 36
Sort By:
Cytometry. Part B, Clinical Cytometry
|
January 18, 2007
Flow cytometric immunphenotyping of epithelial cancer cells in effusions--technical considerations and pitfalls
Hiep P Dong, Arild Holth, Aasmund Berner, et al.
Reproductive Biomedicine Online
|
December 14, 2020
Spatial and temporal changes in follicle distribution in the human ovarian cortex
Annejet Schenck, Maria Vera-Rodriguez, Gareth Greggains, et al.
Human Pathology
|
April 29, 2008
Claudin upregulation in ovarian carcinoma effusions is associated with poor survival
Lilach Kleinberg, Arild Holth, Claes G Trope, et al.
Clinical & Experimental Metastasis
|
April 23, 2003
EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma
Ben Davidson, Iris Goldberg, Aasmund Berner, et al.
Gynecologic Oncology
|
March 25, 2019
SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma
Miriam Sherman-Samis, Hadil Onallah, Arild Holth, et al.
American Journal of Clinical Pathology
|
April 19, 2007
Chemokine receptors are infrequently expressed in malignant and benign mesothelial cells
Ben Davidson, Hiep Phuc Dong, Arild Holth, et al.
Diagnostic Cytopathology
|
March 4, 2006
Fine-needle aspiration cytology of the thyroid gland: comparative analysis of experience at three hospitals
Aasmund Berner, Eva Sigstad, Manohar Pradhan, et al.
The Breast Journal
|
July 29, 2008
The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusions
Ben Davidson, Hiep Phuc Dong, Arild Holth, et al.
Diagnostic Cytopathology
|
August 19, 2007
Flow cytometric immunophenotyping of cancer cells in effusion specimens: diagnostic and research applications
Ben Davidson, Hiep Phuc Dong, Arild Holth, et al.
Human Pathology
|
August 26, 2011
Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions
Mari Bunkholt Elstrand, Helene Tuft Stavnes, Claes G Tropé, et al.
Page
of 36
Search research articles
Search
Showing results (91-100 of 358) with videos related to
Sort By:
Page
of 36
Cytometry. Part B, Clinical Cytometry
|
January 18, 2007
Flow cytometric immunphenotyping of epithelial cancer cells in effusions--technical considerations and pitfalls
Hiep P Dong, Arild Holth, Aasmund Berner, et al.
Reproductive Biomedicine Online
|
December 14, 2020
Spatial and temporal changes in follicle distribution in the human ovarian cortex
Annejet Schenck, Maria Vera-Rodriguez, Gareth Greggains, et al.
Human Pathology
|
April 29, 2008
Claudin upregulation in ovarian carcinoma effusions is associated with poor survival
Lilach Kleinberg, Arild Holth, Claes G Trope, et al.
Clinical & Experimental Metastasis
|
April 23, 2003
EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma
Ben Davidson, Iris Goldberg, Aasmund Berner, et al.
Gynecologic Oncology
|
March 25, 2019
SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma
Miriam Sherman-Samis, Hadil Onallah, Arild Holth, et al.
American Journal of Clinical Pathology
|
April 19, 2007
Chemokine receptors are infrequently expressed in malignant and benign mesothelial cells
Ben Davidson, Hiep Phuc Dong, Arild Holth, et al.
Diagnostic Cytopathology
|
March 4, 2006
Fine-needle aspiration cytology of the thyroid gland: comparative analysis of experience at three hospitals
Aasmund Berner, Eva Sigstad, Manohar Pradhan, et al.
The Breast Journal
|
July 29, 2008
The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusions
Ben Davidson, Hiep Phuc Dong, Arild Holth, et al.
Diagnostic Cytopathology
|
August 19, 2007
Flow cytometric immunophenotyping of cancer cells in effusion specimens: diagnostic and research applications
Ben Davidson, Hiep Phuc Dong, Arild Holth, et al.
Human Pathology
|
August 26, 2011
Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions
Mari Bunkholt Elstrand, Helene Tuft Stavnes, Claes G Tropé, et al.
Page
of 36